Atomi Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Buy
93,562
+30,627
+49% +$3.54M 0.35% 58
2025
Q4
$6.62M Buy
62,935
+23,752
+61% +$2.23M 0.19% 91
2025
Q3
$3.29M Buy
39,183
+6,069
+18% +$500K 0.11% 140
2025
Q2
$2.62M Sell
33,114
-2,132
-6% -$169K 0.1% 152
2025
Q1
$3.16M Buy
35,246
+729
+2% +$68.1K 0.14% 115
2024
Q4
$3.43M Buy
34,517
+3,499
+11% +$361K 0.17% 99
2024
Q3
$3.52M Sell
31,018
-1,282
-4% -$152K 0.22% 88
2024
Q2
$4M Buy
32,300
+4,191
+15% +$540K 0.3% 71
2024
Q1
$3.71M Buy
28,109
+1,012
+4% +$125K 0.34% 64
2023
Q4
$2.95M Buy
27,097
+4,087
+18% +$424K 0.41% 52
2023
Q3
$2.37M Buy
23,010
+1,901
+9% +$205K 0.79% 27
2023
Q2
$2.44M Buy
21,109
+398
+2% +$45.2K 1.11% 9
2023
Q1
$2.2M Buy
+20,711
New +$2.24M 1.23% 15

Other funds holding MRK

Atomi Financial Group's MRK Position: Q1 2026 in Review

Atomi Financial Group increased its Merck (MRK) stake by 49% in Q1 2026, buying an estimated $3.54M and bringing the position to 93,562 shares worth $11.3M. The position accounts for 0.35% of the portfolio, ranked #58.

Atomi Financial Group first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Atomi Financial Group held 93,562 shares of Merck worth $11.3M as of Q1 2026.
  • Atomi Financial Group bought 30,627 Merck shares in Q1 2026, an estimated $3.54M.
  • Merck made up 0.35% of Atomi Financial Group's portfolio in Q1 2026, its #58 holding.
  • Atomi Financial Group first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.